ENTITY
Jinxin Fertility

Jinxin Fertility (1951 HK)

126
Analysis
Health Care • China
Jinxin Fertility Group is a leading international provider of assisted reproductive services (ARS) and assisted reproductive technology (ART). Its core offerings include In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), egg retrieval, embryo transfer, and genetic screening, alongside a range of women's health services. The company is headquartered in Chengdu, China, and was founded in 1951.
more
•17 May 2020 14:18

Hong Kong Buybacks League Table: China Evergrande, Yanzhou Coal, Jinxin Fertility

Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...

Logo
286 Views
Share
•02 Apr 2020 17:41

Bottom Fishing Idea - Jinxin Fertility: IVF Story Intact

Jinxin Fertility has recently reported its results on March 31st. While we don't intend to cover the full result analysis, we would like to...

Logo
501 Views
Share
•27 Feb 2020 11:07

Hygeia Healthcare (海吉亚) Pre-IPO: The Making of Jinxin in the Oncology Segment

Hygeia Healthcare Group, a leading oncology specialized healthcare group, is planning to raise to USD 500 million via a Hong Kong listing. The...

Logo
663 Views
Share
•14 Jan 2020 18:47

Jinxin Fertility (锦欣生殖) Placement - A Good Point of Entry

Shareholders of Jinxin Fertility Co Ltd (1951 HK) is looking to raise US$92m in an accelerated bookbuild. Ke Yan, CFA, FRM has covered the IPO...

Share
•06 Dec 2019 10:31

Jinxin Fertility Lock-Up Expiry Trade: Might Be Worth Doing a Reverse Enquiry

Stakes held by Jinxin Fertility’s pre-IPO investors and cornerstone investors, worth a total of USD 734 million (20% of the market cap), will be...

Logo
658 Views
Share
x